TAKEDA PHARMACEUTICAL COMPANY LIMITED |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 24.37 EUR | +0.87% |
|
+2.39% | -4.97% |
| 07-03 | Blackstone selling Japan drugmaker Alinamin to MBK Partners | RE |
| 07-02 | Koru Medical Systems' FreedomEdge System Receives Regulatory Approval in Japan | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 809B | ||||||
| 621B | ||||||
| 351B | - | - | - | - | ||
| 319B | ||||||
| 289B |
